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doi:10.1016/j.jmii.2011.11.013Background: Antigenemia is commonly found in children with rotavirus infection, although its
clinical significance is undetermined. The aim of this study was to evaluate the association of
antigenemia with clinical manifestations and cytokine profiles in children infected by rotavirus.
Methods: In total, 68 children hospitalized with rotavirus gastroenteritis were enrolled. Serum
sampleswere collected for detection of antigenemia and viremia. Clinical, laboratory and demo-
graphic data were analyzed. Proinflammatory, Th1 and Th2 cytokines were evaluated by bead-
based flow cytometry.
Results: Antigenemia and viremia were found in 45.6% (n Z 31) and 5.9% (n Z 4) of the 68
rotavirus-infectedchildren, respectively. Themeanageof theantigenemiagroupwas significantly
greater than that of the non-antigenemia group (43.5 vs. 27.3 months; pZ 0.034). The antigene-
mia group had a significantly shorter length of hospitalization (4.8 vs. 5.8 days; pZ 0.0354) in
comparison with the non-antigenemia group, and antigenemia was inversely associated with the
lengthofhospitalization (bZ0.31,pZ 0.021). A significantly higher tumornecrosis factor (TNF)-b
level was found in the patients with antigenemia than those without (236.7 vs. 29.2 pg/mL,
pZ 0.026). The severity of disease and the rate of extra-intestinal manifestations did not differ
between the groups. Viremia was associated with a higher fever (pZ 0.012).
Conclusions: Antigenemia was positively correlated with shorter hospital stay in children with
rotavirus infection. Enhanced innate and T-cell-mediated immunity evidenced by up-regulation
of TNF-b was found in patients with antigenemia.
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a commercial EIA approved for detection of rotavirusViral acute gastroenteritis (AGE) is one of the leading
infectious diseases worldwide. Rotavirus is detected in
30e50% of children hospitalized for diarrhea and results in
an estimated 611,000 annual deaths globally.1,2 Previous
studies have addressed whether rotavirus infection is
confined to the intestine.3e5 Rotavirus genome isolated
from the cerebrospinal fluid and serum, and the detection
of live virus in the blood of infected children, has indicated
that rotavirus can escape from the gastrointestinal tract
into the circulatory system and even enter other organs.5e10
Antigenemia is commonly detected in rotavirus-infected
children.11e14 In the acute phase of infection, the detection
of serum rotavirus antigen ranges from 43e90%. Rotavirus
antigen levels usually peak 1 to 3 days after symptom onset
and are undetectable beyond 1 week.11,15 Antigenemia
level is reported to be directly associated with antigen
levels in stools, and inversely related to the titer of specific
anti-rotavirus antibodies in the serum.10,14 Cytokines
mediate the inflammatory process and may influence the
pathogenesis of rotavirus.16,17 There are few studies
addressing the cytokine responses in rotavirus-infected
children.18,19 The role the rotavirus antigenemia plays in
viral pathogenesis and its influence on cytokine expression
and host immunity are still undetermined. The aim of our
study was to investigate the association of antigenemia
with clinical manifestations and cytokine profiles in
rotavirus-infected children.
Materials and methods
Patient selection and specimen collection
Previously healthy patients with ages ranging from 3 months
to 18 years who were admitted to Chang Gung Children’s
Hospital with AGE were randomly enrolled in our study from
October 2007 to September 2008. This study was approved
by the Institutional Review Board of Chang Gung Memorial
Hospital (96-0857B).
Fecal samples for bacterial culture (Salmonella,
Shigella, Campylobacter and Pseudomonas) were obtained.
Adenovirus antigen detection by rapid enzyme immuno-
assay (EIA) analysis and norovirus RNA detection by reverse
transcriptase polymerase chain reaction (RT-PCR) of fecal
samples were also performed. Rotavirus infection was
confirmed by the detection of viral antigen in fecal samples
using a commercial enzyme-linked immunosorbent assay
(ELISA, R-Biopharm, Darmstadt, Germany). Patients with
mixed infections with other viruses or who were coinfected
with bacteria were excluded from the study. Serum and
stool specimens were collected after informed consent was
obtained from parents or guardians. Blood samples were
collected within 3 days after admission for further analysis.
Detection of rotavirus antigens and RNA in serum
specimens
Undiluted serum specimens (50 mL) were tested for the
presence of rotavirus antigen in serum using RotaClone(Meridian Bioscience, Inc., Cincinnati, OH, USA),
antigen in stool. A modified optical density (OD) cutoff
value of 0.3 read by a spectrophotometer VICTOR X3 (J&H
Technology Co. Ltd USA) at a wavelength of 450 nm was
used for serum rotavirus antigen detection, as described in
a previous report.11 An absorbance of 0.3 or greater was
defined as rotavirus antigenemia. The rotavirus RNAs were
extracted from the serum specimens by using a High Pure
Viral Nucleic Acid Kit (Roche Diagnostics GmbH, Mannheim,
Germany) according to the manufacture’s instructions.
Reverse transcription of rotavirus double-strand RNA was
carried out using Superscript III Reverse Transcriptase
(Invitrogen Corporation, Carlsbad, CA, USA). The Beg9 and
VP7-1’ primers selected for the partial sequence of the VP7
gene were based on previous studies.20,21 The PCR condi-
tion for Beg9/ VP7-1’ was: initial incubation at 95C for 5
minutes, followed by 40 cycles at 95C for 15 seconds, 50C
for 30 seconds and 72C for 1 minute, and a final extension
at 72C for 10 minutes. Electrophoresis of the PCR product
was conducted on 2% agarose gels and visualized under
ultraviolet light (Gel Documentation System, Vilber Lour-
mat, France).
Th1 and Th2 cytokine profiling
By using Th1/Th2 FlowCytomix (Bender Medsystem GmbH,
Vienna, Austria), 11 cytokines were measured. Th1 cyto-
kines consisted of interleukin (IL)-2, interferon (IFN)-g,
IL-12, and tumor necrosis factor (TNF)-b. Th2 cytokines
consisted of IL-4, IL-5 and IL-10 (also assigned to
T-regulatory cytokines). The proinflammatory cytokines
IL-1, IL-6, IL-8 and TNF-a were also evaluated simulta-
neously. All serum samples collected were stored at 20C
before testing. The beads plus antibody mixture was
incubated with serially diluted standard or serum samples.
The analytes (cytokines) in the serum specimens bound to
the antibodies linked to the fluorescent beads. A biotin-
conjugated second antibody mixture was added and the
second specific antibodies and bound to the analytes
(cytokines) captured by the first antibodies. The mixture
was incubated at room temperature for 2 hours on
a microplate shaker (500 rpm). Streptavidinephycoery-
thrin (PE) was added and incubated for 1 hour.
StreptavidinePE bound to the biotin conjugate and
emitted fluorescent signals that were detected by flow
cytometry. The fluorescent signals were read and further
calculated by FloCytomix Pro Software (eBioscience,
Vienna, Austria), and correlated cytokine levels were
obtained.
Clinical features and demographic data collection
The clinical features were obtained by detailed history
taking. The items included were age, gender, daily
frequency of diarrhea, duration of diarrhea, daily
frequency of vomiting, duration of vomiting, fever severity
score (0 point: body temperature <37C; 1 point: body
temperature 37.1e38.4C; 2 points: body temperature
38.5e38.9C; 3 points: body temperature S39C),22 fever
duration, blood in stools, length of hospital stay,
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trolytes (normal range: serum sodium 135e145 mmol/L;
serum potassium: 3.5e5.6 mmol/L for 1e6 months; serum
potassium: 3.5e6.1 mmol/L for 6 months to 1 year; serum
potassium: 3.3e4.6 mmol/L for >1 year; serum chloride:
98e106 mmol/L), upper respiratory tract symptoms,
abdominal pain, leukocytosis (leukocyte count >10,000/
mm3), C-reactive protein (CRP, normal range: <5 mg/L ),
and disease severity, using the 0e20 point scoring system
proposed by Vesikari.22 Extra-intestinal manifestations
were also noted if present. Upper respiratory tract infec-
tion (URI) symptoms included cough, rhinorrhea, sore
throat and nasal obstruction, which were not relevant to
recognized atopic diseases or identifiable etiologies pre-
sented during the acute phase of rotavirus illness.
Statistical analysis
The chi-squared test or Fisher’s exact test was applied to
dichotomous variable analysis, and the unpaired-sample
student’s t-test was used for continuous variable analysis.
The p values were two-tailed and those <0.05 were
considered to indicate statistical significance. Multiple
linear regression analysis was used to investigate the asso-
ciation of clinical confounders and the length of hospitali-
zation. The confounders included antigenemia, age, fever
severity, duration of fever, frequency of vomiting, duration
of vomiting, frequency of diarrhea, duration of diarrhea and
severity of dehydration. The SPSS for Windows (version 16;
SPSS, Chicago, IL, USA) was used for statistical analyses.
Results
Demographic data and association of antigenemia
with clinical presentation
From October 2007 to September 2008, 106 hospitalized
pediatric patients were included in our study. Eight had
positive results from stool culture for bacteria, 12 had
positive norovirus infection, seven had mixed viral infec-
tions, four had mixed bacterial and viral infections and
seven had incomplete clinical or laboratory data. These
patients were excluded from the study.
Finally, a total of 68 patients diagnosed with rotavirus
gastroenteritis who had not been vaccinated against rota-
virus were enrolled. There were 44 boys and 24 girls; their
ages ranged from 5 months to 14 years (mean age 34.7
months, median age 25.5 months). An additional five
patients admitted to hospital for causes other than AGE
were enrolled as negative controls. Among the five negative
control patients, there were two boys and three girls with
ages ranging from 6 to 23 months (mean age 14.2 months,
median age 13.0 months). Rotavirus antigen was detected
in the blood of 31/68 (45.6%) patients, and was not found in
the other 37 patients or the negative control group. Serum
rotavirus RNA was positive in four patients. Two of the
patients with viremia had antigenemia.
The patients were divided into antigenemia (nZ 31) and
non-antigenemia (n Z 37) groups. The demographic and
clinical comparison between the two groups is shown in
Table 1. The mean age of the antigenemia group wasgreater than that of the non-antigenemia group
(43.5  36.0 vs. 27.3  25.3 months, p Z 0.034). Mean
hospital stay was significantly shorter (p Z 0.035) in the
antigenemia group (4.9  1.4 days) than in the non-
antigenemia group (5.8  2.1 days). The associations
between clinical confounders and the length of hospital
stay were assessed using a multiple regression model. We
found that antigenemia was inversely associated with the
length of hospital stay (standardized bZ 0.31, pZ 0.021)
while the association of age or other clinical variables and
length of hospital stay was unremarkable. The severity of
vomiting, diarrhea, fever and abdominal pain did not differ
significantly between the two groups. The mean disease
severity, based on the Vesikari scoring system, was 13.0 for
the antigenemia group and 13.3 for the non-antigenemia
group (p Z 0.671). Children with viremia had higher fever
severity score compared with those without (p Z 0.012).
The other clinical presentations of children with viremia
and those without viremia were similar (see Table 1).
Laboratory data
Leukocytosis was detected in 12/31 (38.7%) patients in the
antigenemia group and 16/37 (43.2%) patients in the non-
antigenemia group (p Z 0.705). CRP level was elevated in
17/31 patients with and 23/37 patients without antigenemia
(54.8% vs. 62.2%; pZ 0.541). The majority of CRP levels in
both groups were mildly elevated, without significant
difference in mean value (the mean values were 19 mg/L in
the antigenemia group and 26 mg/L in the non-antigenemia
group; p Z 0.456). Other than leukocyte count and CRP
level, the detection rate of blood in the stools, hypoglycemia
and electrolyte imbalance were similar in both groups.
Extra-intestinal manifestation in rotavirus
gastroenteritis
Upper respiratory tract symptoms were the major extra-
intestinal symptoms in our patients, and they were found in
25.8% of the antigenemia group and 40.5% of the non-
antigenemia group (p Z 0.201). A 14-month-old girl, who
presented with pancreatitis (serum amylase 2449 U/L and
lipase 2021 U/L) during hospitalization, was included in the
non-antigenemia group.
Cytokine profiles
Levels of the Th1 cytokines (IFN-g, IL-2, IL-12 and TNF-b)
were higher in the antigenemia group than in the non-
antigenemia group, except for IFN-g. The TNF-b level
was significantly higher in the non-antigenemia group
(236.7 vs. 29.2 pg/mL, pZ 0.026). There was no significant
difference between the two groups when considering
proinflammatory cytokines (IL-1, IL-6, IL-8 and TNF-a) and
Th2 cytokines (IL-4, IL-5 and IL-10), see Table 2.
Discussion
In our study, the rate of antigenemia (45.6%) in the acute
phase of rotavirus infection was similar to that of previous
Table 1 Comparison of clinical presentations of rotavirus-infected children with or without antigenemia
Antigenemia (n Z 31) Non-antigenemia (n Z 37) P
Age (months) 43.5  36.0 27.3  25.3 0.034y
Gender (male/female) 10/21 23/14 0.632
Clinical presentations
Frequency of diarrhea (times/d) 4.2  2.6 4.0  1.9 0.669
Duration of diarrhea (d) 4.8  1.9 4.8  2.4 0.974
Frequency of vomiting (times/d) 3.3  3.9 2.6  2.2 0.435
Duration of vomiting (d) 2.0  1.3 2.3  1.5 0.452
Fever severity score 2.3  1.1 1.9  1.4 0.164
Fever duration (d) 2.5  1.4 2.3  1.9 0.694
Blood in stool, n (%) 3 (9.7%) 4 (10.8%) 0.878
Upper respiratory tract symptoms, n (%) 8 (25.8%) 15 (40.5%) 0.201
Abdominal pain, n (%) 17 (54.8%) 18 (48.6%) 0.611
Disease severity score 13.0  2.4 13.3  2.2 0.671
Length of hospital stay (d) 4.9  1.4 5.8  2.1 0.035y
Laboratory results
White blood cell count elevation 12 (38.7%) 16 (43.2%) 0.705
C-reactive protein value (mg/L) 19.1  30.5 25.8  40.8 0.456
Hypoglycemia, n (%) 14 (45.2%) 13 (35.1%) 0.400
Abnormal electrolyte, n (%) 5 (16.1%) 3 (8.1%) 0.307
y p < 0.05 indicates statistical significance.
268 T.-H. Yu et al.studies.11,12 Several studies have shown that viremia is
common in rotavirus infection and is transient during the
disease course.14,23 Among the 68 children with rotavirus
infection enrolled in our study, viremia was only found in
four patients. This rate was lower than other reports.10,23
The timing of serum sample collection was considered to
be the determining factor for such a low rate. Positive
serum rotavirus RNA was associated with high fever, and
this finding agrees with a previous study.23 Viremia is
thought to be responsible for more extra-intestinal mani-
festations in rotavirus pathogenesis. Animal models that
simulate the natural course of human rotavirus infection
support the association of transient rotavirus viremia withTable 2 Comparison of serum cytokine profile expressions of
control children
Serum Cytokine profile expressions (pg/ml) Antigenemia (pg/m
IL-1b 28 (0e61.0)
IL-2 137.1 (23.5e184.3
IL-4 208.1 (0e667.9)
IL-5 77.5 (36.3e130.8)
IL-6 83 (19.9e158.5)
IL-8 646.9 (56e1047.7)
IL-10 39.6 (10.5e107.6)
TNF-a 43.6 (0e114.6)
TNF-b 236.7 (27.6e342)
IL-12p70 74.3 (0e154.9)
IFN-g 29.4 (4.1e65.5)
y Mean values and 25% (Q1) and 75% (Q3) quartiles are given as the
*p values were obtained by comparison between the antigenemia gro
significance.extra-intestinal manifestations.24 No positive correlation
was found between viremia and extra-intestinal manifes-
tations in this study, however, due to the limited number of
cases in which viremia was detected.
There have been increasing numbers of reports
describing the presence of rotavirus outside the intestine
and supporting the correlation of rotavirus and extra-
intestinal involvements. One previous report demonstrated
rotavirus nonstructural protein in the livers and kidneys of
immunodeficient children.25 The detection of rotavirus RNA
in cerebrospinal fluid has been described.5,6,8,26 Extra-
intestinal manifestations associated with rotavirus infec-
tion have also been reported, including pancreatitis,27,28rotavirus-infected children with or without antigenemia and
l)y Non-antigenemia (pg/ml)y Control (pg/ml)y P
106.4 (9.9e187.4) 0 (0e0) 0.747
) 78.9 (0e198.7) 0 (0e0) 0.333
228.1 (0e759.8) 0 (0e0) 0.156
66.3 (25.7e187.4) 0 (0e0) 0.440
16.7 (6.4e33.6) 0 (0e0) 0.510
902.6 (34.3e1801.6) 5.29 (0e13.22) 0.370
54 (3.74e149.7) 0 (0e0) 0.440
178.5 (10.9e351.3) 0 (0e0) 0.382
29.2 (0e102.3) 0 (0e0) 0.026*
15.5 (0e48.2) 0 (0e0) 0.544
43.4 (9.7e122) 0 (0e0) 0.145
mean (Q1eQ3).
up and the non-antigenemia group; p < 0.05 indicates statistical
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ditis and pneumonitis,31 encephalitis,32,33 meningoenceph-
alitis,26 cerebellitis,34 convulsions or seizures.8,9 There was
no associated seizure or convulsion in our study population.
Pancreatitis with simultaneous elevated serum trans-
aminase was noted in one patient in our non-antigenemia
group. Our findings suggest that extra-intestinal manifes-
tations or systemic spread were not increased in children
with rotavirus antigenemia, and this result was consistent
with a recent study.35
In clinical studies, elevated levels of IL-6, IL-10, IFN-g,
IFN-a and TNF-a have been reported in children with rota-
virus infection.18,19 Sugata et al reported that IL-8 was
significantly positively correlated but IL-10 was significantly
negatively correlated with rotavirus antigen levels.13 In our
study, a significantly higher TNF-b level was found in the
antigenemia group compared with the non-antigenemia
group. IL-12 (Th1 inducer), IFN-g and IL-2 levels were not
significantly elevated. TNF-b (also known as lymphotoxin-a),
released by Th1 helper cells and CD8 cytotoxic T cells, could
promotemacrophage activation and recruitment to the sites
of infection, strengthening the cytotoxic T cell response.
TNF-b shares receptors with TNF-a and they exert over-
lapping influences on peripheral lymphoid tissues and
immune responses. TNF-b, along with the TNF superfamily,
also constitutes an integral signaling network that is
responsible for effective innate and adaptive immunity.36e38
Based on profile of the cytokines in our study, we propose
that upregulation of TNF-b expression and integral Th1/Th2
cytokines promoted the host immune response against
rotavirus in the antigenemia group and furthermore led to
a shorter hospital stay, but this needs further investigation.
Among the viral pathogens that cause AGE, rotavirus
causes more severe vomiting, diarrhea, fever, and leads to
a significantly higher disease score.39 TNF-a levels have
been reported to correlate with disease severity of rota-
virus infection in children, and did not differ significantly
between the groups in our study.19 One previous study
proposed that higher disease severity scoring exists in
rotavirus-infected children with antigenemia in comparison
with those without antigenemia.35 In that study, however,
lower disease severity might have occurred in asymptom-
atic patients who were mostly distributed in the non-
antigenemia group. Our study enrolled patients who were
all symptomatic; disease severity did not differ between
those with and without antigenemia. Furthermore, anti-
genemia was recognized as a predictor of shorter hospital
stay by a multiple regression model.
Previous studies reported that the production of anti-
bodies after natural rotavirus infection could protect the
host from subsequent different serotypes of rotavirus
infection.40 As the number of rotavirus infections increases,
the anti-rotavirus IgA and IgG titers increase and the rela-
tive risk of subsequent rotavirus infection or rotavirus
diarrhea decrease.41 A longitudinal prospective cohort
study found that naturally acquired serum anti-rotavirus
IgA > 1:800 and IgG > 1:6400 could be reached and
provide efficacious protection against rotavirus infection
and moderate-to-severe diarrhea in children after two
consecutive symptomatic or asymptomatic rotavirus infec-
tions.42 Since rotavirus infection may be subclinical or
asymptomatic and the complexity of individuals’ innate andadaptive immunity background can differ, a further longi-
tudinal prospective cohort study would be needed to
determine the complicated relationships between anti-
genemia, host immune response and clinical presentations.
In summary, our findings indicate that antigenemia is
common in symptomatic rotavirus infection and is more
commonly found in older children. The children with anti-
genemia exhibited upregulated TNF-b production, which
could enhance macrophage activation and cytotoxic T cell
responses leading to acute-stage rotavirus infection being
combatted. Antigenemia in rotavirus infection was associ-
ated with shorter hospital stay and was not associated with
increased disease severity or the occurrence of extra-
intestinal manifestations.Acknowledgments
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